Arthritis and the Disability Tax Credit Canada 2026

Severe arthritis may support DTC eligibility when joint pain, stiffness, or mobility limits markedly restrict daily activities. This guide explains CRA categories, documentation themes, and 2026 credit-value estimates.

Quick Answer

Yes, severe arthritis can qualify for the Disability Tax Credit Canada in 2026. Rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and ankylosing spondylitis qualify when they markedly restrict walking, dressing, or both at least 90% of the time. The cumulative effect rule often applies when no single activity is fully restricted but several are partially restricted.

Educational purposes only. Arthritis DTC eligibility depends on individual joint involvement and functional impact. Consult a qualified tax professional for personal advice.

CRA Categories for Arthritis

Arthritis claims typically rely on one or more of three categories defined by the Canada Revenue Agency:

  • Walking: inability to walk 100 metres on a level surface, even with appropriate aids such as a cane or walker, without stopping due to pain or breathlessness.
  • Dressing: an inordinate amount of time required to dress because of joint pain, stiffness, or limited grip strength.
  • Cumulative effect: restrictions across multiple basic activities, such as walking, dressing, and feeding, that together equal one marked restriction.

Which Arthritis Types Are Most Likely to Qualify

  • Severe rheumatoid arthritis: multiple joint involvement, especially hands, feet, knees, and hips. It often affects both walking and dressing.
  • Advanced osteoarthritis: severe limitation in weight-bearing joints such as hips or knees, especially when surgery has been deferred or failed.
  • Psoriatic arthritis with axial involvement: combined joint and spinal disease creating mobility and dressing limits.
  • Ankylosing spondylitis: advanced spinal fusion limiting walking and self-care.
  • Severe juvenile idiopathic arthritis: marked functional restriction that began in childhood.

Arthritis that is well-controlled on DMARDs or biologics typically does not qualify because the functional limitations are not severe enough.

Key Documentation for Arthritis DTC Claims

  • Rheumatology assessment showing diagnosis, affected joints, and disease activity, such as DAS-28 or a similar measure.
  • Specific functional limits, including walking distance, time needed to dress, grip strength, and ability to open containers.
  • Treatment history, including NSAIDs, DMARDs, biologics, corticosteroids, joint injections, or joint replacements.
  • Radiology evidence, such as X-rays or MRI reports showing erosions, joint space narrowing, or deformity.
  • Use of mobility aids (cane, walker, wheelchair) and dressing aids (button hooks, sock aids)
  • Records of joint surgeries (replacements, fusions, synovectomy) and post-surgical limitations

The 100-Metre Walking Test

For walking-based arthritis claims, the CRA benchmark is whether the person can walk 100 metres on a level surface without stopping. This assessment includes appropriate aids, such as a cane or walker. The medical practitioner should address the distance and the reason walking is limited, including pain, joint deformity, balance, or fatigue.

The Cumulative Effect Rule for Arthritis

Many people with arthritis have moderate restrictions in walking, dressing, and feeding but none reach the marked threshold individually. The cumulative effect rule allows these moderate restrictions to combine. A rheumatologist or family doctor can certify that the combined impact equals a marked restriction in one basic activity.

2026 DTC Amounts for Arthritis

If approved, the federal credit is $1,448 per year. Combined federal plus provincial credit ranges from $2,047 (Ontario) to $3,708 (Québec). Retroactive credits can be significant, but the final amount depends on the CRA-approved years, province, taxable income, transfer rules, and prior returns.

Estimate Your Arthritis DTC Credit

Real arthritis Filing Scenario

The following example is illustrative. It describes a typical filing flow and does not predict any individual outcome.

A Hamilton resident with seropositive rheumatoid arthritis met with her rheumatologist to complete Part B. The rheumatologist documented bilateral hand and wrist inflammation that restricted dressing. Dressing required 45 to 60 minutes, compared with a typical 5 to 10 minutes for someone without the impairment.

The form also documented walking endurance. The resident was limited to short distances before pain forced rest. Part B noted that the restrictions remained even with biologic medication and adaptive tools, and persisted at least 90 percent of waking hours. The Notice of Determination arrived 9 weeks after submission, approving the DTC retroactive to 2022.

Documentation That Works for arthritis Part B

What worked in this Part B: a side-by-side time comparison, such as "45 to 60 minutes versus typical 5 to 10 minutes." The form also clearly stated that the restriction persisted despite treatment. CRA reviewers look for both the duration ratio and the "even with treatment" qualifier in rheumatoid arthritis claims.

See our cumulative effects rule guide for the technical framework CRA reviewers apply. If a previous application was rejected, use our DTC denied appeal guide before resubmitting.

Frequently Asked Questions

Severe osteoarthritis can qualify, especially when weight-bearing joints (hips, knees) are advanced and walking is markedly limited. Mild or moderate osteoarthritis usually does not meet the marked restriction standard.

A rheumatologist provides stronger clinical authority. If your family doctor has been managing your arthritis for years with thorough documentation, they can also certify. For complex cases with biologics or multiple joint surgeries, a rheumatologist's input is preferred.

Possibly, if you still have marked functional restrictions despite treatment. CRA evaluates your functional status with current therapy. Many approved arthritis claims involve people on biologics who continue to have severe mobility or dressing limitations from joint damage that accumulated before effective treatment.

The CRA requires marked restriction at least 90% of the time, but this is judged over time, not by individual days. If your overall pattern, even accounting for better days, shows marked restriction most of the time, you may still qualify. Document this pattern carefully.

Official Sources and Related Guides

This condition guide is based on CRA's Disability Tax Credit criteria and official Form T2201 instructions. Use it with our DTC eligibility guide, T2201 form guide, and DTC calculator. For questions about your own facts, contact Disability Tax Credits Canada or speak with a qualified Canadian tax professional.

How CRA Reviews Arthritis Evidence

For arthritis claims, the CRA does not approve or deny the Disability Tax Credit based on the diagnosis name alone. The reviewer looks for a severe and prolonged impairment. That impairment must create a marked restriction in one basic activity of daily living, a cumulative effect across more than one activity, or qualifying life-sustaining therapy.

The strongest files connect the medical history to everyday function. They use dates, treatment history, frequency, and examples from ordinary routines.

Good arthritis documentation should explain what still happens after treatment, accommodations, medication, assistive devices, or family support are already in place. This helps avoid a common weakness in DTC applications: describing symptoms without showing how those symptoms restrict daily activities at least 90 percent of the time.

  • Functional examples: describe what the person cannot do, needs extra time to do, or can only do with support.
  • Frequency and duration: connect the restriction to CRA's 90 percent and 12-month standards where applicable.
  • Clinical evidence: include treatment history, specialist notes, test results, medication trials, therapy records, or assistive-device use when relevant.
  • Tax context: use the DTC calculator only as an estimate after understanding eligibility through the main DTC guide.

Building a Safer Arthritis Application Path

Before submitting Form T2201, compare the medical practitioner's Part B wording against CRA's published categories. If the evidence is borderline, our cumulative effects guide can help identify whether multiple moderate restrictions combine into a marked overall limitation.

If a previous claim was denied, review the exact denial reason before sending new information. A stronger appeal usually responds to the CRA's stated concern rather than repeating the first application.

Think You May Qualify Estimate Your DTC Amount.